Host immune response and inflammatory cytokine network

The host immune response and inflammatory cytokine network is a complex, multi-layered system of signaling proteins and cellular interactions that orchestrates the body's defense against pathogens and injury. This network encompasses a vast array of molecular players, including pro-inflammatory cytokines like TNF and IL-6, anti-inflammatory cytokines such as IL-10, and chemokines that direct leukocyte trafficking (Source: Nature Reviews Immunology, 2018). In a healthy state, these molecules maintain a delicate balance to resolve threats without damaging host tissue; however, dysregulation of this network is a primary driver of diverse pathologies, including rheumatoid arthritis, inflammatory bowel disease, and acute hyperinflammatory states like sepsis or cytokine release syndrome (Source: New England Journal of Medicine, 2020). From a drug development perspective, this network is not a single target but a collection of highly validated therapeutic nodes. Blockade of specific components—such as TNF-alpha with adalimumab or IL-6 receptors with tocilizumab—has revolutionized the treatment of chronic inflammatory diseases, though systemic modulation carries significant risks of immunosuppression (Source: StatPearls, 2023). Because this entry describes a broad biological system rather than a discrete molecular entity, it is classified as a network rather than a single therapeutic receptor or enzyme.

Other names

Cytokine networkInflammatory cascadeImmune signaling networkCytokine milieuInflammatory cytokine pathway

Therapeutic agents modulate this network by neutralizing specific pro-inflammatory cytokines (e.g., TNF-alpha, IL-1, IL-6), blocking their respective cell-surface receptors, or inhibiting intracellular signaling mediators such as Janus kinases (JAKs) to prevent the transcription of inflammatory genes.